HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Parsol 1789

This article was originally published in The Rose Sheet

Executive Summary

Parsol 1789: FDA tentatively schedules "OTC feedback" meeting with Schering-Plough and Givaudan Roure on Aug. 11 to discuss the UVA/UVB-blocking sunscreen ingredient. Parsol 1789 also was the subject of an "OTC feedback" meeting in March ("The Rose Sheet" March 13, p. 8). Another "OTC feedback" meeting with FDA is set for July 24 to discuss tea tree oil. Representatives of the American Tea Tree Association and the Australian Tea Tree Association will meet with the agency...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel